About Edenwell
Edenwell is a Healthcare company based in India founded in 2017. Clinical research and drug development services in the life sciences sector. Its Indian entity Edenwell Therapeutics Private Limited reported revenue of ₹3.02 Cr. Edenwell offers products and services including Clinical Research Services and Regulatory Services. Its focus areas include Biotechnology, Services, Regulatory Affairs and Life Sciences.
Company details
Edenwell is recognized as a Life Sciences Organization that was established in 2017 to focus on specialty drug development and comprehensive clinical research services. Services such as clinical operations, project management, site feasibility, and regulatory support are offered for trials from Phase I to Phase IV, along with post-marketing studies. These services are directed towards pharmaceutical companies and related entities, emphasizing reliable quality and efficient management. Data management and medical writing are also provided to advance healthcare outcomes through structured processes.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website edenwelltherapeutics.com
- Legal Name Edenwell Therapeutics Private Limited
- Date of Incorporation 19 Jun, 2017
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹3.02 Cr
FY 2024 · +35% YoY
- Net Profit₹2.8 Lakh
FY 2024 · 1% margin
- EBITDA₹5.8 Lakh
FY 2024 · 2% margin
Associated legal entities of Edenwell
Edenwell operates through Edenwell Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Edenwell Therapeutics Private Limited CIN U85320MH2017PTC296318 | Active | 19 Jun 2017 | Thane, Maharashtra | ₹3.0 Cr | 2 | View details |
Products & Services of Edenwell
Edenwell offers a comprehensive portfolio of products and services, including Clinical Research Services and Regulatory Services.
Clinical trials are managed from Phase I to Phase IV, including post-marketing studies, to support drug development
Regulatory affairs are handled for product registration and commercialization in the life sciences field
Board of directors of Edenwell Therapeutics Private Limited (Edenwell)
Edenwell Therapeutics Private Limited is the primary company behind Edenwell. The board of Edenwell Therapeutics Private Limited currently have 2 directors; the longest-serving is Parvez Ahmed Abdulgaffar Kosgi, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Parvez Ahmed Abdulgaffar Kosgi DIN 06557682 | Director | 19 Jun 2017 | 9 yrs 4 mo | Edenwell Therapeutics Private Limited |
| Shoeb Mohammed Kosgi DIN 08284066 | Director | 21 Nov 2018 | 7 yrs 11 mo | Edenwell Therapeutics Private Limited |
Financials of Edenwell
Figures of Edenwell Therapeutics Private Limited, the primary company behind Edenwell, for FY 2024. Revenue was ₹3.02 Cr (+35% year on year). Net profit was ₹2.8 Lakh (1% margin). EBITDA was ₹5.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of +81% over three years and +109% over five years.
- ₹3.02 CrRevenue · FY 2024 · +35% YoY
- ₹2.8 LakhNet profit · 1% margin
- ₹5.8 LakhEBITDA · 2% margin
- ₹1.5 LakhPaid-up capital
- +81%Revenue CAGR, 3 years
- +109%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Edenwell Therapeutics Private Limited are on its company page.
Detailed financial statements for Edenwell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Edenwell (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Edenwell
Edenwell was founded in 2017.
Edenwell is headquartered in India.
The primary company behind Edenwell, Edenwell Therapeutics Private Limited, reported revenue of ₹3.02 Cr for FY 2024, up 35% year on year.
Edenwell is recognized as a Life Sciences Organization that was established in 2017 to focus on specialty drug development and comprehensive clinical research services. Services such as clinical operations, project management, site feasibility, and regulatory support are offered for trials from Phase I to Phase IV, along with post-marketing studies. These services are directed towards pharmaceutical companies and related entities, emphasizing reliable quality and efficient management. Data management and medical writing are also provided to advance healthcare outcomes through structured processes.
Edenwell offers Clinical Research Services and Regulatory Services.
Edenwell operates through Edenwell Therapeutics Private Limited.
The legal entities of Edenwell currently have 2 directors, including Parvez Ahmed Abdulgaffar Kosgi, Shoeb Mohammed Kosgi.